<PAGE> 1
EXHIBIT 99.1
Tuesday January 16, 12:10 pm Eastern Time
Company Press Release
SOURCE: Hyseq, Inc.
Dr. Ted Love joins Hyseq as President
Sunnyvale, CA, January 16, 2001 /PRNewswire/ -- Hyseq, Inc. (Nasdaq: HYSQ)
announced today that it has named Ted W. Love, M.D. as President and Chief
Operating Officer. "I am very excited to join the dynamic team at Hyseq. I
especially look forward to the experience of working with Dr. Rathmann," Dr.
Love said. "Hyseq has discovered a large number of novel genes with its genomics
platform and moving candidates into the clinic is the next important step for
the company," Dr. Love said. Dr. Rathmann continues to serve as Hyseq's Chairman
and Chief Executive Officer. Dr. Love will also join Hyseq's board as a
director.
"Hyseq has focused on selecting biopharmaceutical candidates from our thousands
of full length genes during the past year, with the goal of moving two
candidates into clinical trials as soon as possible. Ted brings significant
experience and expertise to Hyseq to take these candidates into the clinic,"
said Dr. George Rathmann, Hyseq's Chairman and CEO.
Dr. Love brings experience in product development from his six years at
Genentech, Inc. and three years at Advanced Medicine, Inc. Immediately before
joining Hyseq, Dr. Love served as Senior Vice President of Development at
Advanced Medicine, Inc. of San Francisco. Prior to Advanced Medicine, Dr. Love
worked in clinical research, product development, and regulatory affairs at
Genentech, Inc., where his final position was Vice President of Product
Development and Regulatory Affairs. Dr. Love graduated with a B.A. in Molecular
Biology from Haverford College and earned his M.D. from Yale Medical School in
1985. He was a Robert Wood Johnson Foundation Scholar from 1988 to 1992 and
received the International Thrombosis and Haemostasis Young Investigator Award
in 1989. Dr. Love also serves as a Trustee on the Board of Managers of Haverford
College.
Hyseq is researching and developing biopharmaceutical products from its
collection of novel genes discovered using its proprietary high-throughput
technology. Hyseq has collaborations for discovering gene-based products and for
commercializing its HyChip(TM) biochip. Information about Hyseq is available at
www.hyseq.com or by phoning (408) 524-8100.
